IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $66,000 | -59.5% | 1,471 | -48.9% | 0.00% | -66.7% |
| Q4 2020 | $163,000 | +91.8% | 2,881 | +60.0% | 0.00% | +50.0% |
| Q3 2020 | $85,000 | -93.5% | 1,801 | -91.1% | 0.00% | -93.8% |
| Q2 2019 | $1,307,000 | +99.8% | 20,333 | +68.0% | 0.03% | +39.1% |
| Q4 2018 | $654,000 | +114.4% | 12,106 | +104.5% | 0.02% | +109.1% |
| Q3 2018 | $305,000 | +205.0% | 5,919 | +198.6% | 0.01% | +57.1% |
| Q4 2017 | $100,000 | -87.6% | 1,982 | -87.6% | 0.01% | -90.3% |
| Q3 2017 | $809,000 | +13.9% | 15,961 | +14.3% | 0.07% | +2.9% |
| Q2 2017 | $710,000 | +35.5% | 13,959 | +7.1% | 0.07% | +9.4% |
| Q1 2017 | $524,000 | 0.0% | 13,037 | +19.0% | 0.06% | -14.7% |
| Q4 2016 | $524,000 | +38.3% | 10,952 | +5.8% | 0.08% | +29.3% |
| Q3 2016 | $379,000 | +68.4% | 10,347 | +7.4% | 0.06% | +61.1% |
| Q2 2016 | $225,000 | +251.6% | 9,637 | +506.9% | 0.04% | +140.0% |
| Q1 2016 | $64,000 | -31.2% | 1,588 | +5.2% | 0.02% | -31.8% |
| Q4 2015 | $93,000 | – | 1,509 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |